Domů › Rakovina prostaty › Distrikt Kolumbie › Washington
Klinické studie Rakovina prostaty v Washington, DC
38 studií pro Rakovina prostaty hledá účastníky v lokalitách v Washington a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
Probíhá náborFáze 2
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
The Vanguard Study: Testing a New Way to Screen for Cancer
Probíhá náborVítáni zdraví dobrovolníci
- Walter Reed National Military Medical Center, Bethesda · Vzdálenost 7 mi
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
Probíhá náborObservační studie
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Probíhá náborFáze 3
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Probíhá náborObservační studie
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Collection of Blood From Patients With Prostate Cancer
Probíhá náborObservační studie
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · Vzdálenost 7 mi
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Probíhá náborFáze 2
- MedStar Georgetown University Hospital, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Precision-Based Genomics in Prostate Cancer
Probíhá náborObservační studie
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Collection of Blood From Patients With Cancer
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Probíhá náborFáze 3
- MedStar Washington Hospital Center ( Site 0103), Washington D.C.
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
Probíhá náborObservační studie
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
Probíhá náborObservační studie
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
Probíhá náborFáze 2
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Probíhá náborFáze 2
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
Probíhá náborFáze 2
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Probíhá náborFáze 3
- The GW Medical Faculty Associates ( Site 0057), Washington D.C.
- Washington DC Veterans Affairs Medical Center ( Site 0056), Washington D.C.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Probíhá náborFáze 3
- George Washington University Medical Center, Washington D.C.
- UM Capital Region Medical Center, Largo · Vzdálenost 11 mi
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
Probíhá náborObservační studie
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
Probíhá náborFáze 2
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Men at High Genetic Risk for Prostate Cancer
Probíhá náborObservační studie
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
Probíhá náborFáze 1/2
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
Probíhá nábor
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer
Probíhá náborFáze 2
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Probíhá náborFáze 3
- Sibley Memorial Hospital, Washington D.C.
- Suburban Hospital, Bethesda · Vzdálenost 7 mi
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
Probíhá náborFáze 2
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Probíhá náborFáze 3
- Sibley Memorial Hospital, Washington D.C.
- George Washington University Medical Center, Washington D.C.
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Probíhá náborFáze 1
- Maryland Oncology Hematology, Silver Spring · Vzdálenost 7 mi
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Probíhá náborFáze 4
- VA Medical Center, Washington D.C.
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Cancer Support Community Research & Training Institute, Washington D.C.
Clinical Trial of Approaches to Prostate Cancer Surgery
Probíhá nábor
- Georgetown University, Washington D.C.
Castrate Resistant Prostate Cancer Enhertu Therapy
Probíhá náborFáze 2
- Washington DC VAMC, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Probíhá náborFáze 2/3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
Probíhá náborVítáni zdraví dobrovolníci
- Howard University Hospital, Washington D.C.
- National Cancer Institute, Bethesda · Vzdálenost 7 mi
- Walter Reed National Military Medical Center, Bethesda · Vzdálenost 7 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Silver Spring · Vzdálenost 7 mi
- Massive Bio SYNERGY-AI site, Bethesda · Vzdálenost 7 mi
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Probíhá náborFáze 3
- George Washington University Medical Center, Washington D.C.
Studie Rakovina prostaty v jiných městech
- New York City, NY103 studií
- Houston, TX76 studií
- Los Angeles, CA61 studií
- Boston, MA59 studií
- St. Louis, MO46 studií
- Chicago, IL45 studií
- San Francisco, CA45 studií
- Philadelphia, PA44 studií
- Baltimore, MD43 studií
- Nashville, TN43 studií
- Seattle, WA42 studií
- Dallas, TX36 studií
Další studie v Washington
- Rakovina (všechny typy)58 studií
- Nemalobuněčný plicní karcinom55 studií
- Rakovina prsu46 studií
- Metastatický karcinom43 studií
- Rakovina plic41 studií
- Obesity33 studií
- Kolorektální karcinom29 studií
- Kardiovaskulární onemocnění28 studií
- Rakovina močového měchýře26 studií
- Akutní myeloidní leukemie24 studií
- Rakovina vaječníků23 studií
- Lymfom23 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.